Different Types of Vaccines against Pestiviral Infections: “Barriers” for “<i>Pestis</i>”

Different Types of Vaccines against Pestiviral Infections: “Barriers” for “<i>Pestis</i>”

The genus <i>Pestivirus</i> of the family <i>Flaviviridae</i> mainly comprises classical swine fever virus (CSFV), bovine viral diarrhea virus 1 (BVDV-1), BVDV-2, border disease virus (BDV), and multiple new pestivirus species such as atypical porcine pestivirus (APPV), giraf...

Full description

Bibliographic Details
Main Authors:	Mengqi Yuan, Xiaoke Yang, Xin Zhang, Xiaotian Zhao, Muhammad Abid, Hua-Ji Qiu, Yongfeng Li
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Viruses
Subjects:	pestiviruses live attenuated vaccines marker vaccines multivalent vaccines
Online Access:	https://www.mdpi.com/1999-4915/15/1/2

Similar Items

Immunization with <i>centrin</i>-Deficient <i>Leishmania braziliensis</i> Does Not Protect against Homologous Challenge
by: Francys Avendaño-Rangel, et al.
Published: (2024-03-01)

Genetically distinct pestiviruses pave the way to improved classical swine fever marker vaccine candidates based on the chimeric pestivirus concept
by: Alexander Postel, et al.
Published: (2020-01-01)

Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines
by: Laura Rodriguez, et al.
Published: (2019-10-01)

A Synthetic Modified Live Chimeric Marker Vaccine against BVDV-1 and BVDV-2
by: Susanne Koethe, et al.
Published: (2020-10-01)

Current status of vaccine research, development, and challenges of vaccines for Mycoplasma gallisepticum
by: Muhammad Ishfaq, et al.
Published: (2020-09-01)

Live vaccination tactics: possible approaches for controlling visceral leishmaniasis
by: Noushin eSaljoughian, et al.
Published: (2014-03-01)

Rational Development of Live-Attenuated Zika Virus Vaccines
by: Awadalkareem Adam, et al.
Published: (2023-01-01)

Current Approaches to Develop a Live Vaccine against Leishmania majo
by: Farshid Yeganeh, et al.
Published: (2017-06-01)

Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses
by: Brent A. Stanfield, et al.
Published: (2021-08-01)

Summary of the Current Status of African Swine Fever Vaccine Development in China
by: Naijun Han, et al.
Published: (2023-03-01)

Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1
by: Marcel Thalen, et al.
Published: (2020-09-01)

Recent Progress in <i>Shigella</i> and <i>Burkholderia pseudomallei</i> Vaccines
by: Itziar Chapartegui-González, et al.
Published: (2021-10-01)

Effectiveness of Live-Attenuated Genotype III Japanese Encephalitis Viral Vaccine against Circulating Genotype I Viruses in Swine
by: Yi-Chin Fan, et al.
Published: (2022-01-01)

Live Viral Vaccine Neurovirulence Screening: Current and Future Models
by: Corey May Fulton, et al.
Published: (2021-06-01)

Recent Progress in Vaccine Development Against Chikungunya Virus
by: Shan Gao, et al.
Published: (2019-12-01)

Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
by: Majed Ghattas, et al.
Published: (2021-12-01)

Commercial Vaccines Do Not Confer Protection against Two Genogroups of <i>Piscirickettsia salmonis</i>, LF-89 and EM-90, in Atlantic Salmon
by: Carolina Figueroa, et al.
Published: (2022-06-01)

Approaches of dengue control: vaccine strategies and future aspects
by: Runa Akter, et al.
Published: (2024-02-01)

Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis
by: Qingmei Jia, et al.
Published: (2018-05-01)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
by: Saranya Sridhar, et al.
Published: (2015-04-01)

The History of Live Attenuated <i>Centrin</i> Gene-Deleted <i>Leishmania</i> Vaccine Candidates
by: Greta Volpedo, et al.
Published: (2022-04-01)

Live viral vaccines in transplanted patients
by: Arnaud G. L’Huillier, et al.
Published: (2014-09-01)

Attenuation mechanism of Brucella melitensis M5-10, implications for vaccine development and differential diagnosis
by: Yuanqiang ZHENG,Yanchun SHI,Chang AN,Ruisheng LI,Dongjun LIU,Yuehua KE,Kairong MAO,Mingjuan YANG,Zeliang CHEN,Shorgan BOU
Published: (2014-12-01)

Safety of Japanese encephalitis vaccines
by: Ya-Li Hu, et al.
Published: (2021-11-01)

Effectiveness of Booster Measles-Mumps-Rubella Vaccination in Lower COVID-19 Infection Rates: A Retrospective Cohort Study in Turkish Adults
by: Yengil E, et al.
Published: (2021-05-01)

Deletion Mutants of <i>Francisella</i> Phagosomal Transporters FptA and FptF Are Highly Attenuated for Virulence and Are Protective Against Lethal Intranasal <i>Francisella</i> LVS Challenge in a Murine Model of Respiratory Tularemia
by: Brandi E. Hobbs, et al.
Published: (2021-06-01)

New Points of Departure for More Global Influenza Vaccine Use
by: Irina Kiseleva
Published: (2020-07-01)

Broad and Effective Protection against <named-content content-type="genus-species">Staphylococcus aureus</named-content> Is Elicited by a Multivalent Vaccine Formulated with Novel Antigens
by: Jian Deng, et al.
Published: (2019-10-01)

Outbreak of varicella in a highly vaccinated preschool population
by: Jiye Fu, et al.
Published: (2015-08-01)

Typhoid vaccines. Historical aspects of typhoid vaccine development, and currently available products
by: M. V. Abramtseva, et al.
Published: (2021-07-01)

Hand-Foot-and-Mouth Disease-Associated Enterovirus and the Development of Multivalent HFMD Vaccines
by: Xinglong Zhang, et al.
Published: (2022-12-01)

The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy
by: Antonio Volpi, et al.
Published: (2020-02-01)

MicroRNA-Attenuated Virus Vaccines
by: Elizabeth J. Fay, et al.
Published: (2018-10-01)

Cost-Effectiveness of Intranasal Live-Attenuated Influenza Vaccine for Children: A Systematic Review
by: Kenneth Sik-Kwan Chan, et al.
Published: (2022-09-01)

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
by: Pieter T. de Boer, et al.
Published: (2018-12-01)

Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses
by: Yo Han Jang, et al.
Published: (2021-04-01)

Refinement of a Live Attenuated <i>Salmonella enterica</i> Serovar Newport Vaccine with Improved Safety
by: Shamima Nasrin, et al.
Published: (2021-01-01)

Immunization with a Multivalent <i>Listeria monocytogenes</i> Vaccine Leads to a Strong Reduction in Vertical Transmission and Cerebral Parasite Burden in Pregnant and Non-Pregnant Mice Infected with <i>Neospora caninum</i>
by: Dennis Imhof, et al.
Published: (2023-01-01)

An overview of VaxchoraTM, a live attenuated oral cholera vaccine
by: Tarun Saluja, et al.
Published: (2020-01-01)

Herpes zoster vaccination. An update
by: Khairuddin Djawad, et al.
Published: (2022-03-01)